OVID
Ovid Therapeutics (OVID)
$63
About Ovid Therapeutics (OVID)
Ovid Therapeutics, Inc. is a biopharmaceutical company dedicated to pioneering better, gentler medicines for the brain. It discovers and develops differentiated, small molecule medicines for neurological and neuropsychiatric disorders with significant unmet need. The company was founded by Matthew During and Jeremy M. Levin on April 1, 2014 and is headquartered in New York, NY.
Details
Daily high
$2.69
Daily low
$2.60
Price at open
$2.69
52 Week High
$3.10
52 Week Low
$0.50
Market cap
494.6M
Dividend yield
0.00%
Volume
919,698
Avg. volume
1.5M
P/E ratio
-10.90
Ovid Therapeutics News
Details
Daily high
$2.69
Daily low
$2.60
Price at open
$2.69
52 Week High
$3.10
52 Week Low
$0.50
Market cap
494.6M
Dividend yield
0.00%
Volume
919,698
Avg. volume
1.5M
P/E ratio
-10.90